SEASONAL ALLERGIC RHINITIS
Clinical trials for SEASONAL ALLERGIC RHINITIS explained in plain language.
Never miss a new study
Get alerted when new SEASONAL ALLERGIC RHINITIS trials appear
Sign up with your email to follow new studies for SEASONAL ALLERGIC RHINITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New allergy shot shows promise in early trial
Symptom relief CompletedThis Phase 2 trial tested an injection called TQC2938, a humanized monoclonal antibody, in 136 adults with seasonal allergic rhinitis. All participants also used a standard nasal spray. The study measured how well the injection reduced nasal symptoms like sneezing and congestion …
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 22, 2026 11:58 UTC
-
Pre-Treating with fexofenadine eases ragweed allergy symptoms
Symptom relief CompletedThis study tested whether taking the allergy medicine fexofenadine for two days before ragweed pollen season can reduce symptoms like sneezing and runny nose. 95 adults with ragweed allergies participated. Results showed that pre-treatment helped lessen nasal symptoms compared to…
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Symptom relief
Last updated Jun 18, 2026 11:50 UTC
-
New hope for cedar fever sufferers: drug eases severe allergy symptoms
Symptom relief CompletedThis study tested a drug called omalizumab in 337 adults and teens with severe Japanese cedar pollen allergy (hay fever) that standard medicines couldn't control. Participants received either omalizumab or a placebo on top of their usual allergy treatments for 12 weeks. The goal …
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 17, 2026 12:15 UTC